
Vaccine uptake has been declining in Brazil and South Africa over the last decade, reversing gains in protecting children against vaccine-preventable diseases like measles and polio. Both countries have universal and free childhood immunisation programmes, yet Brazil has seen a drop of 10-20 percentage points in coverage since 2016, remaining below the 95% target for routine vaccines. South Africa's vaccination coverage has also steadily declined since 2015.
AI summary. Verify with the original source.
Read full story at The Conversation Africa ↗
Listen
Unlock audio summaries, audio summaries, AI chat, Wikipedia facts, and ad-free reading.
$3.99 / month · cancel anytime
Go PremiumBackground facts
Unlock wikipedia facts, audio summaries, AI chat, Wikipedia facts, and ad-free reading.
$3.99 / month · cancel anytime
Go PremiumSimilar stories

UNAIDS Executive Director Winnie Byanyima has called on the United States to rethink its decision to reduce HIV/AIDS funding for South Africa, emphasizing that this reduction could have severe consequences in a country facing the highest HIV burden globally. Her remarks were made in advance of the UN High-Level Meeting on HIV/AIDS in New York, highlighting concerns over the potential impact of withdrawing support.
Sharp Daily·June 24, 2026 at 7:53 AM
Health-e News discusses the need for health system reform in South Africa to effectively combat tuberculosis (TB). The article emphasizes that while tools to end TB are available, the organization and financing of the health system must be improved to ensure these resources reach those in need.
Health-e News·June 25, 2026 at 7:13 AM
The rollout of lenacapavir (LEN) in Gauteng has faced challenges, with patients in parts of Pretoria being turned away due to delays. It has been two weeks since the initiation of the vaccination program, but access remains limited for some individuals, according to Health-e News.
Health-e News·June 24, 2026 at 6:45 AM
Keletso Mkhwanazi shares their experience receiving lenacapavir, a new HIV prevention injection. Experts indicate that while certain populations are at higher risk for HIV, the jab is available to anyone who is eligible. This article was originally published by Health-e News.
Health-e News·June 11, 2026 at 10:30 AM
The rollout of lenacapavir, a treatment for HIV, is being implemented selectively, raising concerns about who benefits from it and who does not. While lenacapavir was expected to significantly impact the epidemic, the limited geographic distribution highlights issues of access and equity, suggesting that the approach may reflect political decisions rather than a comprehensive strategy to end HIV.
Health-e News·June 5, 2026 at 6:21 AMHealth communication is more effective when conveyed in local languages, as people are more likely to understand and trust information presented in their everyday language. In Africa and many low-resource settings, many individuals have limited proficiency in official languages like English, French, or Portuguese, which can lead to ineffective health messaging when only these languages are used.
HEJNU (UG)·June 13, 2026 at 6:34 PM